Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis

Circulation

Volumn 91, Issue 7, 1995, Pages 2043-2048

  McDonald, Kenneth M ^a,b   Mock, James ^a   D'Aloia, Antonio ^a   Parrish, Todd ^a   Hauer, Kate ^a   Francis, Gary ^a   Stillman, Arthur ^a   Cohn, Jay N ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

angiotensin; bradykinin; enzymes; myocardium; ventricles

Indexed keywords

BRADYKININ; BRADYKININ ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; RAMIPRIL;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG MECHANISM; ENZYME INHIBITION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE MUSCLE; HEART MUSCLE NECROSIS; MEAN ARTERIAL PRESSURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0028905583     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.91.7.2043     Document Type: Article

References (32)

1. Mehta J, Runge W, Cohn JW, Carlyle P. Myocardial damage after repetitive direct current shock in the dog: correlation between left ventricular end-diastolic pressure and extent of myocardial necrosis. J Lab Clin Med. 1978;91:272-279.
2. McDonald KM, Francis GS, Carlyle PF, Hauer K, Matthews J, Hunter DW, Cohn JN. Hemodynamic, left ventricular structural and humoral changes after discrete myocardial damage in the dog. J Am Coll Cardiol. 1992;19:460-467.
3. McDonald KM, Zhang J, Yoshiyama M, Francis GS, Ugurbil K, Cohn JN. Abnormal myocardial bioenergetics in canine asymptomatic left ventricular dysfunction. J Am Coll Cardiol. 1994;23: 786-793.
4. McDonald KM, Carlyle PF, Mathews J, Hauer K, Elbers T, Hunter D, Cohn JN. Early ventricular remodeling after myocardial damage and its attenuation by converting enzyme inhibition. Trans Assoc Am Physicians. 1990;103:229-235.
5. McDonald KM, Garr MD, Carlyle PF, Francis GS, Hauer K, Hunter DW, Parrish T, Stillman A, Cohn JN. The relative effects of alpha, adrenoceptor blockade, converting enzyme inhibitor therapy and angiotensin II subtype I receptor blockade on ventricular remodeling in the dog. Circulation. 1994;90:3034-3036.
6. Farhy RD, Carretero OA, Ho K-L, Scicli G. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res. 1993;72:1202-1210.
7. Linz W, Schölkens BA. A specific β2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril. Br J Pharmacol. 1992;105:771-772.
8. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990;81:1161-1172.
9. Anversa P, Sonnenblick EH. Ischemic cardiomyopathy: pathophysiologic mechanisms. Prog Cardiovasc Dis. 1990;33:49-70.
10. Beltrami CA, Finato N, Roco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation. 1994;89:151-163.
11. McKay RG, Pfeffer MA, Pasternak RC, Markis JE, Come PC, Nakao S, Alderman JD, Ferguson JJ, Safian RD, Grossman W. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986;74:693-702.
12. St John Sutton M, Pfeffer MA, Plapport T, Rouleau J-L, Moyé LA, Dagenais GR, Lamas GA, Klein M, Sussex B, Goldman S, Menapace EJ, Parker JO, Lewis S, Sestier F, Gordon DF, McEwan P, Bernstein V, Braunwald E, for the SAVE Investigators. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction: the protective effects of captopril. Circulation. 1994;89:68-75.
13. Sharpe N, Smith H, Murphy J, Hannon S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Eur Heart J. 1990;11(suppl B):147-150.
14. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988;319:80-86.
15. Belichard P, Savard P, Cardinal R, Nadeau R, Gosselin H, Paradis P, Rouleau JL. Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias. J Am Coll Cardiol. 1994;23:505-513.
16. Raya TE, Gay RG, Aguirre M, Goldman S. Importance of venodilatation in prevention of left ventricular dilatation after chrome large myocardial infarction in rats: a comparison of captopril and hydralazine. Circ Res. 1989;64:330-337.
17. 1) angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol. 1990;258:H806-H813.
18. Morgan HE, Baker KM. Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation. 1991;83:13-25.
19. Brilla CG. Angiotensin II type 2 receptor-mediated stimulation of collagen synthesis in human cardiac fibroblasts. Circulation. 1992; 86(suppl I):I-89. Abstract.
20. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and the renin-angiotensin-aldosterone system. Circulation. 1991;83:1849-1865.
21. Raya TE, Fonker SJ, Lee RW, Daugherty S, Goldman S, Wong PC, Timmermans PBMWM, Morkin E. Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in a rat model of heart failure. Am J Hypertens. 1991;4:334S-340S.
22. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz T, Reide UN, Drexler H. Comparative effects of chronic angiotensin-converting enzyme inhibitor and angiotensin II type I receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation. 1994;89:2273-2282.
23. Garg VC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
24. deBlois D, Lombardi DM, Garvin MA, Schwartz SM. Inhibition by ramipril of intimai hyperplasia in the denuded rat carotid is reversed by Hoe 140, a kinin B2 receptor antagonist. Circulation. 1992;86(suppl I):I-226. Abstract.
25. McDonald KM, Francis GS, Matthews J, Hunter DW, Cohn JN. Chronic oral nitrate therapy prevents long-term ventricular remodeling in the dog. J Am Coll Cardiol. 1993;21:514-522.
26. Olivetti G, Ricci R, Beghi C, Giuderi R, Anversa P. Response of the border zone to myocardial infarction in the rat. Am J Pathol. 1986;125:476-483.
27. McDonald KM, Toher C, Parrish T, Stillman A, Cohn J. The effect of ramipril on right ventricular remodeling following left ventricular damage. Cardiovasc Drugs Ther. 1993;7:404. Abstract.
28. Gohlke P, Linz W, Schölkens BA, Kuwer I, Bartenbach S, Schnell A, Unger T. Angiotensin-converting enzyme inhibition improves cardiac function: role of bradykinin. Hypertension. 1994;23:411-418.
29. Bao G, Gohlke P, Unger TH. Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models. J Cardiovasc Pharmacol. 1992;20(suppl 9):S96-S99.
30. Benetos A, Gavras H, Stewart JM, Vavrek RJ, Hatinoglou S, Gavras I. Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist. Hypertension. 1986;8:971-974.
31. Danckwardt L, Shimizu I, Bönner G, Rettig R, Unger TH. Converting enzyme inhibition in kinin-deficicnt Brown Norway rats. Hypertension. 1990;16:429-435.
32. Carbonell LF, Carretero OA, Stewart JM, Scicli AG. Effect of a kinin antagonist on the acute antihypertensive activity of enalapril in severe hypertension. Hypertension. 1988;11:239-243.